Caffeine intake and dementia: systematic review and meta-analysis.
about
Nutrition and the risk of Alzheimer's diseaseThe neuroprotective effects of cocoa flavanol and its influence on cognitive performanceCoffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cellsFDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicityProof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia.Can coffee consumption lower the risk of Alzheimer's disease and Parkinson's disease? A literature review.Gas chromatography time-of-flight mass spectrometry (GC-TOF-MS)-based metabolomics for comparison of caffeinated and decaffeinated coffee and its implications for Alzheimer's disease.Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.Effects of coffee/caffeine on brain health and disease: What should I tell my patients?Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation.Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's DiseaseSweetened beverages, coffee, and tea and depression risk among older US adultsStuck at the bench: Potential natural neuroprotective compounds for concussion.Caffeine and alcohol intakes have no association with risk of multiple sclerosis.Inconsistency of Association between Coffee Consumption and Cognitive Function in Adults and Elderly in a Cross-Sectional Study (ELSA-Brasil)Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study.Coffee intake in midlife and risk of dementia and its neuropathologic correlates.Caffeine and cognitive decline in elderly women at high vascular risk.Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization studyCaffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans.Free radical biology of the cardiovascular system.Health benefits of methylxanthines in neurodegenerative diseases.How does adenosine control neuronal dysfunction and neurodegeneration?Is the Ergogenicity of Caffeine Affected by Increasing Age? The Direct Effect of a Physiological Concentration of Caffeine on the Power Output of Maximally Stimulated EDL and Diaphragm Muscle Isolated from the Mouse.Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline.Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study.Association between Coffee Consumption and Incident Risk of Disabling Dementia in Elderly Japanese: The Ohsaki Cohort 2006 Study.Acute doses of caffeine shift nervous system cell expression profiles toward promotion of neuronal projection growth.Altered motility of plaque-associated microglia in a model of Alzheimer's disease.Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.Distinct sensitivity to caffeine-induced insomnia related to age.Informatics for Nutritional Genetics and Genomics.Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A2A Receptor in Hippocampal Glutamate Synapses.Caffeine consumption disrupts hippocampal long-term potentiation in freely behaving rats.Habitual coffee consumption and cognitive function: a Mendelian randomization meta-analysis in up to 415,530 participants.Why Do You Drink Caffeine? The Development of the Motives for Caffeine Consumption Questionnaire (MCCQ) and Its Relationship with Gender, Age and the Types of Caffeinated BeveragesThe Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's DiseasePhenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation
P2860
Q22241959-7E007A3B-7359-45A9-9635-3E0FA2E17BDFQ22242634-9B2276A1-99F3-43B5-9EC0-264B260A073BQ28385402-4CB5CF2B-526C-41AF-B5C1-64E96FD897E0Q28478041-20B7DBD2-3B06-4314-9610-4FFEB7649921Q30426397-30200BE3-4E33-427C-AE86-D7B4D3DA0A6BQ33645947-95EA3964-3E7D-4B71-83ED-024D27EAAE9CQ34011240-67AEA504-6510-472E-97CA-6280F7349273Q34189447-A7DC06C4-70A1-4C97-BC16-DC5E45A9F6F3Q34505480-D283528C-79BF-4EF3-9C26-91FFA4AA52F3Q34540333-8AB0FC53-5BC2-4CDB-A8C7-8150BDA42AF2Q35030119-E3B13D43-6F15-40DD-97D2-9D658383AEFDQ35151652-B52E3439-619E-4F1E-A2DA-1F4AB6D45B1EQ35493114-1CD30D23-B58D-4244-B9DC-0CD2BC4881A1Q36210020-4290A10E-AFB4-4694-A62C-81C233FB6AAAQ36329946-3D090727-1D4A-495D-9DC4-76612725DC51Q36623334-27325336-5048-4C9C-B825-311F5DE5B966Q37063687-29938A7E-1713-418A-AA63-2AEAFCE2D213Q37252507-45E72869-91FF-4C1A-B2A5-982D700BB3B7Q37413986-57B139B7-C2DF-411E-8C74-30FF920216CBQ37581186-114844E0-B20D-4183-B401-AFE2CCD84C04Q37997802-C3AC0968-6633-4215-8C6E-F2AE0D26F349Q38772021-C5DDDA3B-A003-4C4C-B4A4-292DFB20227DQ38882782-A79A4C98-244D-4EFC-9B12-8D0BFAB5AC62Q39202371-64AA4539-F64E-43C6-BF0E-342C60B8D117Q39779135-2CA8BB83-F5F1-416A-A7BC-BEE6156C1F30Q40563346-0B9EF5CB-8C2B-4B09-B749-686ABA84063CQ40761772-1B92281B-F82C-4D82-A09F-B310BB84D7FCQ41038186-F4E285D0-5998-43FD-BEB7-BB51C37662A4Q41126059-0762CAAD-CA0A-48E9-966F-2C0A5ABABBF3Q42174672-F946CF08-6AC4-4BD2-BFFE-5751E6342760Q42269908-9FDC132D-C72B-4F47-A28D-E12CA8087B0AQ47628064-06940897-3309-44E5-B2D1-30FA614524F8Q47668620-2F6970A5-45C0-49A3-937A-B8D74C31C23CQ48064385-D7489FCE-C917-45D1-9768-136DE4A23E42Q50420575-601ECBDE-4F0F-43FA-977B-F32FB5E37096Q55114605-5E76D744-4918-457F-9C8A-C1E85A957FC4Q56639275-28DBE1E6-0E98-4CC1-B024-EA7FF69B3B37Q57896320-8FB6E384-C9CD-41F0-A0E7-D1D23E2056D5Q58122620-30AC3DBB-5151-4072-8152-666DA56D4F4A
P2860
Caffeine intake and dementia: systematic review and meta-analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Caffeine intake and dementia: systematic review and meta-analysis.
@ast
Caffeine intake and dementia: systematic review and meta-analysis.
@en
Caffeine intake and dementia: systematic review and meta-analysis.
@nl
type
label
Caffeine intake and dementia: systematic review and meta-analysis.
@ast
Caffeine intake and dementia: systematic review and meta-analysis.
@en
Caffeine intake and dementia: systematic review and meta-analysis.
@nl
prefLabel
Caffeine intake and dementia: systematic review and meta-analysis.
@ast
Caffeine intake and dementia: systematic review and meta-analysis.
@en
Caffeine intake and dementia: systematic review and meta-analysis.
@nl
P2093
P356
P1476
Caffeine intake and dementia: systematic review and meta-analysis
@en
P2093
Catarina Santos
João Costa
João Santos
P304
P356
10.3233/JAD-2010-091387
P478
20 Suppl 1
P577
2010-01-01T00:00:00Z